Fulcrum Therapeutics, Inc. (FULC)
6.61
+0.26
(+4.09%)
USD |
NASDAQ |
May 21, 16:00
6.61
0.00 (0.00%)
After-Hours: 19:59
Fulcrum Therapeutics EPS Diluted (Quarterly) : -0.2479 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.89M |
| Total Expenses (Quarterly) | 18.89M |
| Enterprise Value | 95.67M |
| Earnings Yield | -17.34% |
| Normalized Earnings Yield | -17.35 |